Cover
Cover - shares | 6 Months Ended | |
Jun. 30, 2024 | Aug. 12, 2024 | |
Document Information [Line Items] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Entity Interactive Data Current | Yes | |
Amendment Flag | false | |
Document Period End Date | Jun. 30, 2024 | |
Document Fiscal Year Focus | 2024 | |
Document Fiscal Period Focus | Q2 | |
Entity Information [Line Items] | ||
Entity Registrant Name | REFLECT SCIENTIFIC, INC. | |
Entity Central Index Key | 0001103090 | |
Entity File Number | 000-31377 | |
Entity Tax Identification Number | 87-0642556 | |
Entity Incorporation, State or Country Code | UT | |
Current Fiscal Year End Date | --12-31 | |
Entity Current Reporting Status | Yes | |
Entity Shell Company | false | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Contact Personnel [Line Items] | ||
Entity Address, Address Line One | 1266 South 1380 West | |
Entity Address, City or Town | Orem | |
Entity Address, State or Province | UT | |
Entity Address, Postal Zip Code | 84058 | |
Entity Phone Fax Numbers [Line Items] | ||
City Area Code | (801) | |
Local Phone Number | 226-4100 | |
Entity Listings [Line Items] | ||
Entity Common Stock, Shares Outstanding | 85,664,086 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) | Jun. 30, 2024 | Dec. 31, 2023 |
Current Assets | ||
Cash and cash equivalents | $ 1,102,696 | $ 1,277,951 |
Accounts receivable, net | 110,592 | 108,191 |
Inventories, net | 835,667 | 972,293 |
Prepaid expenses and other current assets | 14,550 | 11,715 |
Total Current Assets | 2,063,505 | 2,370,150 |
Operating lease right-of-use assets | 200,026 | 235,653 |
Goodwill | 60,000 | 60,000 |
Other long-term assets | 3,100 | 3,100 |
TOTAL ASSETS | 2,326,631 | 2,668,903 |
Current Liabilities | ||
Accounts payable and accrued expenses | 52,904 | 86,241 |
Customer deposits | 90,369 | 447,444 |
Current portion of operating lease liabilities | 72,802 | 62,681 |
Total Current Liabilities | 216,075 | 596,366 |
Operating lease liabilities, net of current portion | 140,966 | 179,963 |
TOTAL LIABILITIES | 357,041 | 776,329 |
Stockholders' Equity | ||
Preferred Stock, $0.01 par value, 5,000,000 shares authorized; none issued and outstanding as of June 30, 2024 and December 31, 2023 | ||
Common stock, $0.01 par value, 100,000,000 shares authorized; 85,664,086 shares issued and outstanding as of June 30, 2024 and December 31, 2023 | 856,640 | 856,640 |
Additional paid-in capital | 20,302,681 | 20,302,681 |
Accumulated deficit | (19,189,731) | (19,266,747) |
TOTAL STOCKHOLDERS’ EQUITY | 1,969,590 | 1,892,574 |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ 2,326,631 | $ 2,668,903 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares | Jun. 30, 2024 | Dec. 31, 2023 |
Statement of Financial Position [Abstract] | ||
Preferred stock, par value (in Dollars per share) | $ 0.01 | $ 0.01 |
Preferred stock, shares authorized | 5,000,000 | 5,000,000 |
Preferred stock, shares issued | ||
Preferred stock, shares outstanding | ||
Common stock, par value (in Dollars per share) | $ 0.01 | $ 0.01 |
Common stock, shares authorized | 100,000,000 | 100,000,000 |
Common stock, shares issued | 85,664,086 | 85,664,086 |
Common stock, shares outstanding | 85,664,086 | 85,664,086 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Income Statement [Abstract] | ||||
Revenues | $ 590,071 | $ 124,384 | $ 1,018,826 | $ 365,511 |
Cost of goods sold | 231,514 | 63,850 | 418,480 | 177,483 |
Gross profit | 358,557 | 60,534 | 600,346 | 188,028 |
Operating Expenses | ||||
Salaries and wages | 148,054 | 154,569 | 290,668 | 316,844 |
General and administrative | 107,555 | 81,361 | 239,859 | 188,353 |
Research and development | 4,605 | 5,380 | 11,980 | 11,446 |
Total Operating Expenses | 260,214 | 241,310 | 542,507 | 516,643 |
INCOME (LOSS) FROM OPERATIONS | 98,343 | (180,776) | 57,839 | (328,615) |
INTEREST INCOME | 10,644 | (312) | 19,177 | (312) |
NET INCOME (LOSS) BEFORE INCOME TAXES | 98,343 | (180,776) | 57,839 | (328,615) |
INCOME TAX EXPENSE | ||||
NET INCOME (LOSS) | $ 108,987 | $ (181,088) | $ 77,016 | $ (328,927) |
Income (loss) per common share | ||||
Income (loss) per common share - basic (in Dollars per share) | $ 0 | $ 0 | $ 0 | $ 0 |
Weighted average shares outstanding | ||||
Weighted average shares outstanding - basic (in Shares) | 85,664,086 | 85,214,086 | 85,664,086 | 85,214,086 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals) - $ / shares | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Income Statement [Abstract] | ||||
Income (loss) per common share - diluted | $ 0 | $ 0 | $ 0 | $ 0 |
Weighted average shares outstanding - diluted | 85,664,086 | 85,214,086 | 85,664,086 | 85,214,086 |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Stockholders’ Equity - USD ($) | Common Shares | Additional Paid-In Capital | Accumulated Deficit | Total |
Balance at Dec. 31, 2022 | $ 852,140 | $ 20,252,181 | $ (18,807,719) | $ 2,296,602 |
Balance (in Shares) at Dec. 31, 2022 | 85,214,086 | |||
Stock-based compensation | 6,875 | 6,875 | ||
Net Income (loss) | (147,839) | (147,839) | ||
Balance at Mar. 31, 2023 | $ 852,140 | 20,259,056 | (18,955,558) | 2,155,638 |
Balance (in Shares) at Mar. 31, 2023 | 85,214,086 | |||
Balance at Dec. 31, 2022 | $ 852,140 | 20,252,181 | (18,807,719) | 2,296,602 |
Balance (in Shares) at Dec. 31, 2022 | 85,214,086 | |||
Net Income (loss) | (328,927) | |||
Balance at Jun. 30, 2023 | $ 852,140 | 20,265,931 | (19,136,646) | 1,981,425 |
Balance (in Shares) at Jun. 30, 2023 | 85,214,086 | |||
Balance at Mar. 31, 2023 | $ 852,140 | 20,259,056 | (18,955,558) | 2,155,638 |
Balance (in Shares) at Mar. 31, 2023 | 85,214,086 | |||
Stock-based compensation | 6,875 | 6,875 | ||
Net Income (loss) | (181,088) | (181,088) | ||
Balance at Jun. 30, 2023 | $ 852,140 | 20,265,931 | (19,136,646) | 1,981,425 |
Balance (in Shares) at Jun. 30, 2023 | 85,214,086 | |||
Balance at Dec. 31, 2023 | $ 856,640 | 20,302,681 | (19,266,747) | 1,892,574 |
Balance (in Shares) at Dec. 31, 2023 | 85,664,086 | |||
Net Income (loss) | (31,971) | (31,971) | ||
Balance at Mar. 31, 2024 | $ 856,640 | 20,302,681 | (19,298,718) | 1,860,603 |
Balance (in Shares) at Mar. 31, 2024 | 85,664,086 | |||
Balance at Dec. 31, 2023 | $ 856,640 | 20,302,681 | (19,266,747) | 1,892,574 |
Balance (in Shares) at Dec. 31, 2023 | 85,664,086 | |||
Net Income (loss) | 77,016 | |||
Balance at Jun. 30, 2024 | $ 856,640 | 20,302,681 | (19,189,731) | 1,969,590 |
Balance (in Shares) at Jun. 30, 2024 | 85,664,086 | |||
Balance at Mar. 31, 2024 | $ 856,640 | 20,302,681 | (19,298,718) | 1,860,603 |
Balance (in Shares) at Mar. 31, 2024 | 85,664,086 | |||
Net Income (loss) | 108,987 | 108,987 | ||
Balance at Jun. 30, 2024 | $ 856,640 | $ 20,302,681 | $ (19,189,731) | $ 1,969,590 |
Balance (in Shares) at Jun. 30, 2024 | 85,664,086 |
Condensed Consolidated Statem_4
Condensed Consolidated Statements of Cash Flows - USD ($) | 6 Months Ended | |
Jun. 30, 2024 | Jun. 30, 2023 | |
CASH FLOWS FROM OPERATING ACTIVITIES | ||
Net income (loss) | $ 77,016 | $ (328,927) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Stock-based compensation | 13,750 | |
Amortization of right-of-use assets | 35,627 | 29,257 |
Changes in operating assets and liabilities: | ||
Accounts receivable | (2,401) | 36,612 |
Inventories | 136,626 | (79,734) |
Prepaid expenses and other current assets | (2,835) | (3,703) |
Accounts payable and accrued expenses | (33,338) | (35,398) |
Customer deposits | (357,075) | 425,607 |
Operating lease liabilities | (28,876) | (30,633) |
Net cash (used in) provided by operating activities | (175,255) | 26,831 |
CASH FLOWS FROM INVESTING ACTIVITIES | ||
Net cash provided by investing activities | ||
CASH FLOWS FROM FINANCING ACTIVITIES | ||
Net cash provided by financing activities | ||
NET CHANGE IN CASH AND CASH EQUIVALENTS | (175,255) | 26,831 |
CASH AND CASH EQUIVALENTS | ||
Beginning of the period | 1,277,951 | 1,381,927 |
End of the period | 1,102,696 | 1,408,758 |
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION | ||
Cash paid for interest | ||
Cash paid for income taxes |
Basis of Presentation and Other
Basis of Presentation and Other Information | 6 Months Ended |
Jun. 30, 2024 | |
Basis of Presentation and Other Information [Abstract] | |
BASIS OF PRESENTATION AND OTHER INFORMATION | NOTE 1—BASIS OF PRESENTATION AND OTHER INFORMATION The accompanying unaudited condensed consolidated financial statements of Reflect Scientific, Inc. (the “Company,” “we,” “us,” or “our”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q of Regulation S-X. They do not include all the information and footnotes required by GAAP for complete financial statements. The December 31, 2023 consolidated balance sheet data was derived from audited financial statements but do not include all disclosures required by GAAP. However, except as disclosed herein, there has been no material change in the information disclosed in the notes to the consolidated financial statements for the year ended December 31, 2023 included in the Company’s Annual Report on Form 10-K, as filed with the Securities and Exchange Commission on March 29, 2024. The interim unaudited condensed consolidated financial statements should be read in conjunction with those consolidated financial statements included in the Form 10-K. In the opinion of management, all adjustments considered necessary for a fair presentation of the financial statements, consisting solely of normal recurring adjustments, have been made. Operating results for the three and six months ended June 30, 2024 are not necessarily indicative of the results that may be expected for the year ending December 31, 2024. Recently Issued Accounting Pronouncements In November 2023, the FASB issued ASU 2023-07, “ Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures In December 2023, the FASB issued ASU 2023-09, “ Income Taxes (Topic 740): Improvements to Income Tax Disclosures The Company currently believes there are no other issued and not yet effective accounting standards that are materially relevant to our condensed consolidated financial statements. |
Disaggregation of Revenues
Disaggregation of Revenues | 6 Months Ended |
Jun. 30, 2024 | |
Disaggregation of Revenues [Abstract] | |
DISAGGREGATION OF REVENUES | NOTE 2—DISAGGREGATION OF REVENUES Our revenue is disaggregated based on product category and geographical region. We recognize revenue from the sale of scientific equipment for the life sciences and manufacturing industries. Our products include non-mechanical Cyrometrix freezers, chillers, and original equipment manufacturer (“OEM”) value-added products and components for the life sciences industry. The Company’s revenues for the three months ended June 30, 2024 and 2023 are disaggregated as follows: For the Three Months Ended June 30, 2024 United States International Total Revenues Freezers and chillers $ 391,198 $ - $ 391,198 OEM and other 159,385 39,488 198,873 Total Revenues $ 550,583 $ 39,488 $ 590,071 For the Three Months Ended June 30, 2023 United States International Total Revenues Freezers and chillers $ 10,508 $ - $ 10,508 OEM and other 81,155 32,721 113,876 Total Revenues $ 91,663 $ 32,721 $ 124,384 The Company’s revenues for the six months ended June 30, 2024 and 2023 are disaggregated as follows: Six Months Ended June 30, 2024 United States International Total Revenues Freezers and chillers $ 655,468 $ - $ 655,468 OEM and other 297,181 66,177 363,358 Total Revenues $ 952,649 $ 66,177 $ 1,018,826 Six Months Ended June 30, 2023 United States International Total Revenues Freezers and chillers $ 55,758 $ - $ 55,758 OEM and other 209,035 100,718 309,753 Total Revenues $ 264,793 $ 100,718 $ 365,511 |
Inventories
Inventories | 6 Months Ended |
Jun. 30, 2024 | |
Inventories [Abstract] | |
INVENTORIES | NOTE 3—INVENTORIES Inventories at June 30, 2024 and December 31, 2023 consisted of the following: June 30, December 31, 2024 2023 Finished goods $ 184,808 $ 493,565 Raw materials 756,903 584,772 Total inventories 941,711 1,078,337 Less reserve for obsolescence (106,044 ) (106,044 ) Total inventories, net $ 835,667 $ 972,293 Inventory balances are composed of finished goods and raw materials. Work in process inventory is immaterial to the condensed consolidated financial statements. |
Leases
Leases | 6 Months Ended |
Jun. 30, 2024 | |
Leases [Abstract] | |
LEASES | NOTE 4—LEASES The following was included in our condensed consolidated balance sheets at June 30, 2024 and December 31, 2023: June 30, December 31, 2024 2023 Operating lease right-of-use assets $ 200,026 $ 235,653 Lease liabilities, current portion 72,802 62,681 Lease liabilities, long-term 140,966 179,963 Total operating lease liabilities $ 213,768 $ 242,644 Weighted-average remaining lease term (months) 29 35 Weighted average discount rate 10.5 % 10.5 % Total lease expense for the three and six months ended June 30, 2024 and 2023 is as follows: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Operating lease expense $ 23,875 $ 15,216 $ 47,750 $ 30,432 Variable lease expense - 7,202 - 11,639 Total lease expense $ 23,875 $ 22,418 $ 47,750 $ 42,071 Cash payments included in the measurement of our operating lease liabilities were $20,777 and $15,977 for the three months ended and $41,002 and $31,808 for the six months ended June 30, 2024 and 2023, respectively. As of June 30, 2024, maturities of operating lease liabilities were as follows: Year Ending December 31, Amount 2024 $ 44,307 2025 98,532 2026 101,708 Total 244,547 Less: imputed interest (30,779 ) Total operating lease liabilities $ 213,768 |
Stockholders' Equity
Stockholders' Equity | 6 Months Ended |
Jun. 30, 2024 | |
Stockholders' Equity [Abstract] | |
STOCKHOLDERS’ EQUITY | NOTE 5—STOCKHOLDERS’ EQUITY Common Stock As of June 30, 2024 and December 31, 2023, the Company was authorized to issue 100,000,000 common shares, of which 85,664,086 common shares were issued and outstanding. |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) | 3 Months Ended | 6 Months Ended | ||||
Jun. 30, 2024 | Mar. 31, 2024 | Jun. 30, 2023 | Mar. 31, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Pay vs Performance Disclosure | ||||||
Net Income (Loss) | $ 108,987 | $ (31,971) | $ (181,088) | $ (147,839) | $ 77,016 | $ (328,927) |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended |
Jun. 30, 2024 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
Rule 10b5-1 Arrangement Modified | false |
Non-Rule 10b5-1 Arrangement Modified | false |
Accounting Policies, by Policy
Accounting Policies, by Policy (Policies) | 6 Months Ended |
Jun. 30, 2024 | |
Accounting Policies [Abstract] | |
Recently Issued Accounting Pronouncements | Recently Issued Accounting Pronouncements In November 2023, the FASB issued ASU 2023-07, “ Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures In December 2023, the FASB issued ASU 2023-09, “ Income Taxes (Topic 740): Improvements to Income Tax Disclosures The Company currently believes there are no other issued and not yet effective accounting standards that are materially relevant to our condensed consolidated financial statements. |
Disaggregation of Revenues (Tab
Disaggregation of Revenues (Tables) | 6 Months Ended |
Jun. 30, 2024 | |
Disaggregation of Revenues [Abstract] | |
Schedule of Disaggregated Revenues | The Company’s revenues for the three months ended June 30, 2024 and 2023 are disaggregated as follows: For the Three Months Ended June 30, 2024 United States International Total Revenues Freezers and chillers $ 391,198 $ - $ 391,198 OEM and other 159,385 39,488 198,873 Total Revenues $ 550,583 $ 39,488 $ 590,071 For the Three Months Ended June 30, 2023 United States International Total Revenues Freezers and chillers $ 10,508 $ - $ 10,508 OEM and other 81,155 32,721 113,876 Total Revenues $ 91,663 $ 32,721 $ 124,384 Six Months Ended June 30, 2024 United States International Total Revenues Freezers and chillers $ 655,468 $ - $ 655,468 OEM and other 297,181 66,177 363,358 Total Revenues $ 952,649 $ 66,177 $ 1,018,826 Six Months Ended June 30, 2023 United States International Total Revenues Freezers and chillers $ 55,758 $ - $ 55,758 OEM and other 209,035 100,718 309,753 Total Revenues $ 264,793 $ 100,718 $ 365,511 |
Inventories (Tables)
Inventories (Tables) | 6 Months Ended |
Jun. 30, 2024 | |
Inventories [Abstract] | |
Schedule of Inventories | Inventories at June 30, 2024 and December 31, 2023 consisted of the following: June 30, December 31, 2024 2023 Finished goods $ 184,808 $ 493,565 Raw materials 756,903 584,772 Total inventories 941,711 1,078,337 Less reserve for obsolescence (106,044 ) (106,044 ) Total inventories, net $ 835,667 $ 972,293 |
Leases (Tables)
Leases (Tables) | 6 Months Ended |
Jun. 30, 2024 | |
Leases [Abstract] | |
Schedule of Consolidated Balance Sheet | The following was included in our condensed consolidated balance sheets at June 30, 2024 and December 31, 2023: June 30, December 31, 2024 2023 Operating lease right-of-use assets $ 200,026 $ 235,653 Lease liabilities, current portion 72,802 62,681 Lease liabilities, long-term 140,966 179,963 Total operating lease liabilities $ 213,768 $ 242,644 Weighted-average remaining lease term (months) 29 35 Weighted average discount rate 10.5 % 10.5 % |
Schedule of Lease Expense | Total lease expense for the three and six months ended June 30, 2024 and 2023 is as follows: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Operating lease expense $ 23,875 $ 15,216 $ 47,750 $ 30,432 Variable lease expense - 7,202 - 11,639 Total lease expense $ 23,875 $ 22,418 $ 47,750 $ 42,071 |
Schedule of Maturities of Operating Lease Liabilities | As of June 30, 2024, maturities of operating lease liabilities were as follows: Year Ending December 31, Amount 2024 $ 44,307 2025 98,532 2026 101,708 Total 244,547 Less: imputed interest (30,779 ) Total operating lease liabilities $ 213,768 |
Disaggregation of Revenues (Det
Disaggregation of Revenues (Details) - Schedule of Disaggregated Revenues - USD ($) | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Revenues | ||||
Total Revenues | $ 590,071 | $ 124,384 | $ 1,018,826 | $ 365,511 |
United States [Member] | ||||
Revenues | ||||
Total Revenues | 550,583 | 91,663 | 952,649 | 264,793 |
International [Member] | ||||
Revenues | ||||
Total Revenues | 39,488 | 32,721 | 66,177 | 100,718 |
Freezers and Chillers [Member] | ||||
Revenues | ||||
Total Revenues | 391,198 | 10,508 | 655,468 | 55,758 |
Freezers and Chillers [Member] | United States [Member] | ||||
Revenues | ||||
Total Revenues | 391,198 | 10,508 | 655,468 | 55,758 |
Freezers and Chillers [Member] | International [Member] | ||||
Revenues | ||||
Total Revenues | ||||
OEM and Other [Member] | ||||
Revenues | ||||
Total Revenues | 198,873 | 113,876 | 363,358 | 309,753 |
OEM and Other [Member] | United States [Member] | ||||
Revenues | ||||
Total Revenues | 159,385 | 81,155 | 297,181 | 209,035 |
OEM and Other [Member] | International [Member] | ||||
Revenues | ||||
Total Revenues | $ 39,488 | $ 32,721 | $ 66,177 | $ 100,718 |
Inventories (Details) - Schedul
Inventories (Details) - Schedule of Inventories - USD ($) | Jun. 30, 2024 | Dec. 31, 2023 |
Schedule of Inventories [Abstract] | ||
Finished goods | $ 184,808 | $ 493,565 |
Raw materials | 756,903 | 584,772 |
Total inventories | 941,711 | 1,078,337 |
Less reserve for obsolescence | (106,044) | (106,044) |
Total inventories, net | $ 835,667 | $ 972,293 |
Leases (Details)
Leases (Details) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Leases [Abstract] | ||||
Operating lease | $ 20,777 | $ 15,977 | $ 41,002 | $ 31,808 |
Leases (Details) - Schedule of
Leases (Details) - Schedule of Condensed Consolidated Balance Sheet - USD ($) | Jun. 30, 2024 | Dec. 31, 2023 |
Schedule of Consolidated Balance Sheet [Abstract] | ||
Operating lease right-of-use assets | $ 200,026 | $ 235,653 |
Lease liabilities, current portion | 72,802 | 62,681 |
Lease liabilities, long-term | 140,966 | 179,963 |
Total operating lease liabilities | $ 213,768 | $ 242,644 |
Weighted-average remaining lease term (months) | 29 months | 35 months |
Weighted average discount rate | 10.50% | 10.50% |
Leases (Details) - Schedule o_2
Leases (Details) - Schedule of Lease Expense - USD ($) | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Schedule of Lease Expense [Abstract] | ||||
Operating lease expense | $ 23,875 | $ 15,216 | $ 47,750 | $ 30,432 |
Variable lease expense | 7,202 | 11,639 | ||
Total lease expense | $ 23,875 | $ 22,418 | $ 47,750 | $ 42,071 |
Leases (Details) - Schedule o_3
Leases (Details) - Schedule of Maturities of Operating Lease Liabilities - USD ($) | Jun. 30, 2024 | Dec. 31, 2023 |
Schedule of Maturities of Operating Lease Liabilities [Abstract] | ||
2024 | $ 44,307 | |
2025 | 98,532 | |
2026 | 101,708 | |
Total | 244,547 | |
Less: imputed interest | (30,779) | |
Total operating lease liabilities | $ 213,768 | $ 242,644 |
Stockholders' Equity (Details)
Stockholders' Equity (Details) - shares | Jun. 30, 2024 | Dec. 31, 2023 |
Stockholders' Equity [Line Items] | ||
Common stock, shares authorized | 100,000,000 | 100,000,000 |
Common stock, shares issued | 85,664,086 | 85,664,086 |
Common stock, shares outstanding | 85,664,086 | 85,664,086 |